Genprex, Inc. (GNPX)
1.685
-0.22
(-11.32%)
USD |
NASDAQ |
Nov 17, 16:00
1.685
0.00 (0.00%)
After-Hours: 20:00
Genprex Price : 1.685 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2.01 | 2.135 | 1.830 | 1.90 | 116099.0 |
| Nov 13, 2026 | 2.26 | 2.26 | 2.06 | 2.08 | 11527.00 |
| Nov 12, 2026 | 2.30 | 2.30 | 2.20 | 2.21 | 19038.00 |
| Nov 11, 2026 | 2.11 | 2.38 | 2.11 | 2.29 | 161330.0 |
| Nov 10, 2026 | 2.10 | 2.20 | 2.07 | 2.09 | 158109.0 |
| Nov 09, 2026 | 2.07 | 2.155 | 2.05 | 2.06 | 87425.00 |
| Nov 06, 2026 | 2.11 | 2.13 | 2.02 | 2.07 | 100092.0 |
| Nov 05, 2026 | 2.25 | 2.25 | 1.950 | 2.10 | 223784.0 |
| Nov 04, 2026 | 2.35 | 2.35 | 2.14 | 2.14 | 251064.0 |
| Nov 03, 2026 | 2.24 | 2.38 | 2.24 | 2.31 | 144994.0 |
| Nov 02, 2026 | 2.33 | 2.368 | 2.159 | 2.23 | 243416.0 |
| Oct 30, 2026 | 2.04 | 2.27 | 2.02 | 2.24 | 184017.0 |
| Oct 29, 2026 | 1.86 | 2.10 | 1.86 | 2.04 | 155274.0 |
| Oct 28, 2026 | 1.94 | 2.05 | 1.834 | 2.01 | 110610.0 |
| Oct 27, 2026 | 1.86 | 1.965 | 1.71 | 1.95 | 112560.0 |
| Oct 26, 2026 | 1.86 | 1.874 | 1.791 | 1.81 | 76521.00 |
| Oct 23, 2026 | 2.08 | 2.08 | 1.79 | 1.81 | 215202.0 |
| Oct 22, 2026 | 1.99 | 2.05 | 1.98 | 1.98 | 94933.00 |
| Oct 21, 2026 | 2.20 | 2.20 | 1.910 | 2.05 | 362917.0 |
| Oct 20, 2026 | 2.07 | 2.18 | 2.03 | 2.13 | 234302.0 |
| Oct 19, 2026 | 2.15 | 2.215 | 2.06 | 2.06 | 246402.0 |
| Oct 16, 2026 | 2.27 | 2.32 | 2.10 | 2.11 | 127910.0 |
| Oct 15, 2026 | 2.30 | 2.43 | 2.215 | 2.29 | 225949.0 |
| Oct 14, 2026 | 2.50 | 2.55 | 2.30 | 2.33 | 281620.0 |
| Oct 13, 2026 | 2.65 | 2.692 | 2.51 | 2.51 | 170804.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.30 |
| Alnylam Pharmaceuticals, Inc. | 156.54 |
| Anika Therapeutics, Inc. | 12.89 |
| Savara, Inc. | 4.475 |
| Arrowhead Pharmaceuticals, Inc. | 42.96 |
Price Related Metrics
| Price to Book Value | 0.1497 |
| Earnings Yield | -3.21K% |
| Market Cap | 2.054M |